Fennell R S, Orak J K, Hudson T, Garin E H, Iravani A, Richard G A, Hislop S L, Knight M I
Eur J Pediatr. 1984 Aug;142(3):174-8. doi: 10.1007/BF00442444.
Eighteen infants, children, and adolescents were trained in the techniques of continuous ambulatory peritoneal dialysis (CAPD) as a therapy for end stage renal disease (ESRD) at the University of Florida. Fourteen patients successfully continued CAPD 4-24 months, for a total of 193 patient-months. Uremic symptoms were well controlled with blood urea nitrogen concentration (BUN) decreased to between 60 and 80 mg/dl. Parathyroid hormone levels increased but roentgenographic evidence of osteodystrophy improved in most patients. The rate of peritonitis was one episode in 7.7 patient-months. Blood transfusion requirements decreased for patients transferred from in-center hemodialysis to CAPD with no significant decrease in average hematocrits. Caloric intake was adequate and anorexia was usually not a major problem. Children who were evaluated for growth were under 15 years of age, with bone ages less than 12 years, and were using CAPD for longer than 6 months. Their mean growth velocity was 74.7 +/- 20.4% (SD) of the predicted velocity.
18名婴儿、儿童和青少年在佛罗里达大学接受了持续性非卧床腹膜透析（CAPD）技术培训，该技术用于治疗终末期肾病（ESRD）。14名患者成功进行了4至24个月的CAPD治疗，总计193个患者月。尿毒症症状得到良好控制，血尿素氮浓度（BUN）降至60至80mg/dl之间。甲状旁腺激素水平升高，但大多数患者骨营养不良的X线证据有所改善。腹膜炎发生率为每7.7个患者月发生1次。从中心血液透析转为CAPD的患者输血需求减少，平均血细胞比容无显著下降。热量摄入充足，厌食通常不是主要问题。接受生长评估的儿童年龄在15岁以下，骨龄小于12岁，且使用CAPD超过6个月。他们的平均生长速度为预测速度的74.7±20.4%（标准差）。
